Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168947 · ClinicalTrials.gov registry record · NA
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
A NA study, sponsored by Renal Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01168947 is a NA study that has completed, run by Renal Research Institute. The registered enrollment target is 17 participants.
The verdict
NCT01168947, a NA study, has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Sodium loading during hemodialysis treatment is common and may contribute to increased interdialytic weight gain and hypertension. Excessive use of isotonic saline (containing 0.9% sodium chloride) is one of the factors that may cause sodium loading. During each hemodialysis session, approximately 400 mL of isotonic saline fluid, representing 1.4 grams of sodium, is used to prime and rinse the extracorporeal circuit, and is often administered to the patient. Switching to a non sodium-containing priming and rinsing fluid could allow for removal of the equivalent amount of sodium. Switching to a non sodium-containing solution for the priming and rinsing of the extracorporeal circuit can contribute to increased sodium removal during the dialysis treatment and allow for reduced interdialytic weight gain, reduced thirst, and improved blood pressure control.
Interventions
- OTHER 5% dextrose solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01168947
The ClinicalTrials.gov registry entry for NCT01168947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 5% dextrose solution is the first listed.
NCT01168947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01168947 about?
NCT01168947 is a clinical study titled "Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain". Sodium loading during hemodialysis treatment is common and may contribute to increased interdialytic weight gain and hypertension. Excessive use of isotonic saline (containing 0.9% sodium chloride) is one of the factors that may cause sodium loading. During each hemodialysis session, approximately 4...
What is the current status of trial NCT01168947?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01168947?
The interventions under investigation include: 5% dextrose solution (OTHER).
Who is sponsoring clinical trial NCT01168947?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.